{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:07:45Z","timestamp":1781071665522,"version":"3.54.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Postgraduate Research & Practice Innovation Program of Jiangsu Province","award":["KYCX23_2469"],"award-info":[{"award-number":["KYCX23_2469"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21807049"],"award-info":[{"award-number":["21807049"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001711"],"award-info":[{"award-number":["82001711"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["JUSRP51703A"],"award-info":[{"award-number":["JUSRP51703A"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012613","name":"University-Industry Cooperation Research Project in Jiangsu","doi-asserted-by":"publisher","award":["BY2020432"],"award-info":[{"award-number":["BY2020432"]}],"id":[{"id":"10.13039\/501100012613","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20201137"],"award-info":[{"award-number":["BK20201137"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation of Wuxi Municipal Health Commission","award":["HB2023023"],"award-info":[{"award-number":["HB2023023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-024-02180-6","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T11:47:09Z","timestamp":1736250429000},"page":"2137-2151","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluating the Anti-inflammatory Potential of JN-KI3: The Therapeutic Role of PI3K\u03b3-Selective Inhibitors in Asthma Treatment"],"prefix":"10.1007","volume":"48","author":[{"given":"Lei","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendian","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9553-1765","authenticated-orcid":false,"given":"Jian","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"2180_CR1","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1002\/med.21770","volume":"41","author":"J Zhu","year":"2021","unstructured":"Zhu, J., K. Li, L. Yu, Y. Chen, Y. Cai, J. Jin, et al. 2021. Targeting phosphatidylinositol 3-kinase gamma (PI3Kgamma): Discovery and development of its selective inhibitors. Medicinal Research Reviews 41:1599\u20131621.","journal-title":"Medicinal Research Reviews"},{"key":"2180_CR2","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3390\/biom9090427","volume":"9","author":"Beer-Hammer N\u00fcrnberg","year":"2019","unstructured":"N\u00fcrnberg, Beer-Hammer. 2019. Function, Regulation and Biological Roles of PI3K\u03b3 Variants. Biomolecules 9: 427.","journal-title":"Biomolecules"},{"key":"2180_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.pharmthera.2014.09.006","volume":"146","author":"TM Bauer","year":"2015","unstructured":"Bauer, T. M., M. R. Patel, and J. R. Infante. 2015. Targeting PI3 kinase in cancer. Pharmacology & Therapeutics 146:53\u201360.","journal-title":"Pharmacology & Therapeutics"},{"key":"2180_CR4","doi-asserted-by":"publisher","first-page":"114824","DOI":"10.1016\/j.ejmech.2022.114824","volume":"244","author":"Y Jiang","year":"2022","unstructured":"Jiang, Y., W. Xiong, L. Jia, L. Xu, Y. Cai, Y. Chen, et al. 2022. Developing a Naive Bayesian Classification Model with PI3Kgamma structural features for virtual screening against PI3Kgamma: Combining molecular docking and pharmacophore based on multiple PI3Kgamma conformations. European Journal of Medicinal Chemistry 244:114824.","journal-title":"European Journal of Medicinal Chemistry"},{"key":"2180_CR5","doi-asserted-by":"publisher","first-page":"105642","DOI":"10.1016\/j.compbiomed.2022.105642","volume":"147","author":"L Jia","year":"2022","unstructured":"Jia, L., L. Wang, Y. Jiang, L. Xu, Y. Cai, Y. Chen, et al. 2022. Exploring PI3Kgamma binding preference with Eganelisib, Duvelisib, and Idelalisib via energetic, pharmacophore and dissociation pathway analyses. Computers in Biology and Medicine 147:105642.","journal-title":"Computers in Biology and Medicine"},{"key":"2180_CR6","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.drudis.2015.03.009","volume":"20","author":"Zhu Jingyu","year":"2015","unstructured":"Jingyu, Zhu, Hou Tingjun, and Mao Xinliang. 2015. Discovery of selective phosphatidylinositol 3-kinase inhibitors to treat hematological malignancies. Drug Discovery Today 20:988\u2013994.","journal-title":"Drug Discovery Today"},{"key":"2180_CR7","doi-asserted-by":"publisher","first-page":"8559","DOI":"10.1021\/jm300847w","volume":"55","author":"TD Cushing","year":"2012","unstructured":"Cushing, T. D., D. P. Metz, et al. 2012. PI3K\u03b4 and PI3K\u03b3 as Targets for Autoimmune and Inflammatory Diseases. Journal of Medicinal Chemistry 55:8559\u20138581.","journal-title":"Journal of Medicinal Chemistry"},{"key":"2180_CR8","first-page":"1971","volume":"50","author":"WD Xiong","year":"2023","unstructured":"Xiong, W. D., L. Jia, Y. F. Cai, Y. Chen, J. Jin, and J. Y. Zhu. 2023. Investigation Into The Anti-inflammation and PI3K? Inhibitory Preference of Eganelisib. Progress in Biochemistry and Biophysics 50:1971\u20131981.","journal-title":"Progress in Biochemistry and Biophysics"},{"key":"2180_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.chembiol.2010.01.010","volume":"17","author":"O Williams","year":"2010","unstructured":"Williams, O., B. Houseman, T. Kunkel, et al. 2010. Discovery of dual inhibitors of the immune cell PI3Ks p110d and p110g: a prototype for new anti-inflammatory drugs. Chemistry & Biology 17:123\u2013134.","journal-title":"Chemistry & Biology"},{"key":"2180_CR10","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41577-022-00701-8","volume":"22","author":"SM Lanahan","year":"2022","unstructured":"Lanahan, S. M., M. P. Wymann, and C. L. Lucas. 2022. The role of PI3Kgamma in the immune system: New insights and translational implications. Nature Reviews Immunology 22:687\u2013700.","journal-title":"Nature Reviews Immunology"},{"key":"2180_CR11","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature20554","volume":"539","author":"OD Henau","year":"2016","unstructured":"Henau, O. D., M. Rausch, D. Winkler, L. F. Campesato, C. Liu, D. H. Cymerman, et al. 2016. Overcoming resistance to checkpoint blockade therapy by targeting PI3K\u03b3 in myeloid cells. Nature 539:443\u2013447.","journal-title":"Nature"},{"key":"2180_CR12","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nature19834","volume":"539","author":"MM Kaneda","year":"2016","unstructured":"Kaneda, M. M., K. S. Messer, N. Ralainirina, H. Li, C. J. Leem, S. Gorjestani, et al. 2016. PI3K\u03b3 is a molecular switch that controls immune suppression. Nature 539:437\u2013442.","journal-title":"Nature"},{"key":"2180_CR13","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.tips.2023.06.002","volume":"44","author":"D Cirillo","year":"2023","unstructured":"Cirillo, D., M. Diceglie, and M. Nazar\u00e9. 2023. Isoform-selective targeting of PI3K: Time to consider new opportunities? Trends in Pharmacological Sciences 44:601\u2013621.","journal-title":"Trends in Pharmacological Sciences"},{"key":"2180_CR14","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/S0140-6736(17)33311-1","volume":"391","author":"A Papi","year":"2018","unstructured":"Papi, A., C. Brightling, S.E. Pedersen, and H.K. Reddel. 2018. Asthma. The Lancet 391:783\u2013800.","journal-title":"The Lancet"},{"key":"2180_CR15","first-page":"429","volume":"8","author":"N Akar-Ghibril","year":"2020","unstructured":"Akar-Ghibril, N., T. Casale, A. Custovic, and W. Phipatanakul. 2020. Allergic Endotypes and Phenotypes of Asthma. The Journal of Allergy and Clinical Immunology: In Practice 8:429\u2013440.","journal-title":"The Journal of Allergy and Clinical Immunology: In Practice"},{"key":"2180_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrd4624","volume":"15","author":"NA Gandhi","year":"2016","unstructured":"Gandhi, N. A., B. L. Bennett, N. Graham, G. Pirozzi, N. Stahl, and G. D. Yancopoulos. 2016. Targeting key proximal drivers of type 2 inflammation in disease. Nature Reviews. Drug Discovery 15:35\u201350.","journal-title":"Nature Reviews. Drug Discovery"},{"key":"2180_CR17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1160\/TH07-10-0632","volume":"99","author":"L Barberis","year":"2008","unstructured":"Barberis, L., and E. Hirsch. 2008. Targeting phosphoinositide 3-kinase gamma to fight inflammation and more. Thrombosis and Haemostasis 99:279\u2013285.","journal-title":"Thrombosis and Haemostasis"},{"key":"2180_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/bies.200900150","volume":"32","author":"A Ghigo","year":"2010","unstructured":"Ghigo, A., F. Damilano, L. Braccini, and E. Hirsch. 2010. PI3K inhibition in inflammation: Toward tailored therapies for specific diseases. BioEssays 32:185\u2013196.","journal-title":"BioEssays"},{"key":"2180_CR19","doi-asserted-by":"publisher","first-page":"109102","DOI":"10.1016\/j.intimp.2022.109102","volume":"111","author":"W Xiong","year":"2022","unstructured":"Xiong, W., L. Jia, J. Liang, Y. Cai, Y. Chen, Y. Nie, et al. 2022. Investigation into the anti-airway inflammatory role of the PI3Kgamma inhibitor JN-PK1: An in vitro and in vivo study. International Immunopharmacology 111:109102.","journal-title":"International Immunopharmacology"},{"key":"2180_CR20","doi-asserted-by":"publisher","first-page":"5232","DOI":"10.1038\/s41467-018-07698-6","volume":"9","author":"CC Campa","year":"2018","unstructured":"Campa, C. C., R. L. Silva, J. P. Margaria, T. Pirali, M. S. Mattos, L. R. Kraemer, et al. 2018. Inhalation of the prodrug PI3K inhibitor CL27c improves lung function in asthma and fibrosis. Nature Communications 9:5232.","journal-title":"Nature Communications"},{"key":"2180_CR21","doi-asserted-by":"publisher","first-page":"152747","DOI":"10.1016\/j.tox.2021.152747","volume":"454","author":"CY Xu","year":"2021","unstructured":"Xu, C. Y., S. Y. Chen, Y. Deng, J. F. Song, J. H. Li, X. Chen, et al. 2021. Distinct roles of PI3K\u03b4 and PI3K\u03b3 in a toluene diisocyanate-induced murine asthma model. Toxicology 454:152747.","journal-title":"Toxicology"},{"key":"2180_CR22","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.pupt.2013.11.006","volume":"27","author":"Y Saito","year":"2014","unstructured":"Saito, Y., M. Takeda, J. Nishikawa, Y. Konno, M. Tamaki, M. Itoga, et al. 2014. The effect of pharmacological PI3K\u03b3 inhibitor on eotaxin-induced human eosinophil functions. Pulmonary Pharmacology & Therapeutics 27:164\u2013169.","journal-title":"Pulmonary Pharmacology & Therapeutics"},{"key":"2180_CR23","doi-asserted-by":"publisher","first-page":"152753","DOI":"10.1016\/j.imbio.2023.152753","volume":"228","author":"W Xiong","year":"2023","unstructured":"Xiong, W., L. Jia, Y. Cai, Y. Chen, M. Gao, J. Jin, et al. 2023. Evaluation of the anti-inflammatory effects of PI3K\u03b4\/\u03b3 inhibitors for treating acute lung injury. Immunobiology 228:152753.","journal-title":"Immunobiology"},{"key":"2180_CR24","doi-asserted-by":"publisher","first-page":"107879","DOI":"10.1016\/j.compbiolchem.2023.107879","volume":"104","author":"JY Zhu","year":"2023","unstructured":"Zhu, J. Y., D. Sun, X. T. Li, L. Jia, Y. F. Cai, Y. Chen, et al. 2023. Developing new PI3K\u03b3 inhibitors by combining pharmacophore modeling, molecular dynamic simulation, molecular docking, fragment-based drug design, and virtual screening. Computational Biology and Chemistry 104:107879.","journal-title":"Computational Biology and Chemistry"},{"key":"2180_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jare.2021.04.007","volume":"36","author":"J Zhu","year":"2022","unstructured":"Zhu, J., K. Li, L. Xu, Y. Cai, Y. Chen, X. Zhao, et al. 2022. Discovery of novel selective PI3Kgamma inhibitors through combining machine learning-based virtual screening with multiple protein structures and bio-evaluation. Journal of Advanced Research 36:1\u201313.","journal-title":"Journal of Advanced Research"},{"key":"2180_CR26","doi-asserted-by":"publisher","first-page":"703724","DOI":"10.3389\/fphar.2021.703724","volume":"12","author":"L Xue","year":"2021","unstructured":"Xue, L., C. Li, G. Ge, S. Zhang, L. Tian, Y. Wang, et al. 2021. Jia-Wei-Yu-Ping-Feng-San Attenuates Group 2 Innate Lymphoid Cell-Mediated Airway Inflammation in Allergic Asthma. Frontiers in Pharmacology 12:703724.","journal-title":"Frontiers in Pharmacology"},{"key":"2180_CR27","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13287-020-02072-0","volume":"12","author":"L Dong","year":"2021","unstructured":"Dong, L., Y. Wang, T. Zheng, Y. Pu, Y. Ma, X. Qi, et al. 2021. Hypoxic hUCMSC-derived extracellular vesicles attenuate allergic airway inflammation and airway remodeling in chronic asthma mice. Stem Cell Research & Therapy 12:4.","journal-title":"Stem Cell Research & Therapy"},{"key":"2180_CR28","doi-asserted-by":"publisher","first-page":"115768","DOI":"10.1016\/j.ejmech.2023.115768","volume":"260","author":"X Liang","year":"2023","unstructured":"Liang, X., M. Deng, F. Zou, Z. Qi, C. Wang, J. Liu, et al. 2023. Discovery of Pyrazolo[1,5-a]pyrimidine derivative as a potent and selective PI3K\u03b3\/\u03b4 dual inhibitor. European Journal of Medicinal Chemistry 260:115768.","journal-title":"European Journal of Medicinal Chemistry"},{"key":"2180_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mcn.2016.11.002","volume":"78","author":"N Schneble","year":"2017","unstructured":"Schneble, N., C. Schmidt, R. Bauer, J. P. M\u00fcller, S. Monajembashi, and R. Wetzker. 2017. Phosphoinositide 3-kinase \u03b3 ties chemoattractant- and adrenergic control of microglial motility. Molecular and Cellular Neuroscience 78:1\u20138.","journal-title":"Molecular and Cellular Neuroscience"},{"key":"2180_CR30","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3389\/fimmu.2019.01084","volume":"10","author":"M Orecchioni","year":"2019","unstructured":"Orecchioni, M., Y. Ghosheh, A.B. Pramod, and K. Ley. 2019. Macrophage Polarization: Different Gene Signatures in M1(LPS+) vs. Classically and M2(LPS-) vs. Alternatively Activated Macrophages. Front Immunol 10:1084.","journal-title":"Front Immunol"},{"key":"2180_CR31","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3109\/08830185.2014.969421","volume":"34","author":"L Zhu","year":"2015","unstructured":"Zhu, L., Q. Zhao, T. Yang, W. Ding, and Y. Zhao. 2015. Cellular metabolism and macrophage functional polarization. International Reviews of Immunology 34:82\u2013100.","journal-title":"International Reviews of Immunology"},{"key":"2180_CR32","doi-asserted-by":"publisher","first-page":"e148548","DOI":"10.1172\/JCI148548","volume":"132","author":"CG Peace","year":"2022","unstructured":"Peace, C. G., and L. A. O\u2019Neill. 2022. The role of itaconate in host defense and inflammation. The Journal of Clinical Investigation 132:e148548.","journal-title":"The Journal of Clinical Investigation"},{"key":"2180_CR33","doi-asserted-by":"publisher","first-page":"585595","DOI":"10.3389\/fimmu.2021.585595","volume":"12","author":"P Lertnimitphun","year":"2021","unstructured":"Lertnimitphun, P., W. Zhang, W. Fu, B. Yang, C. Zheng, M. Yuan, et al. 2021. Safranal Alleviated OVA-Induced Asthma Model and Inhibits Mast Cell Activation. Frontiers in Immunology 12:585595.","journal-title":"Frontiers in Immunology"},{"key":"2180_CR34","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.biopha.2017.04.133","volume":"91","author":"TT Bui","year":"2017","unstructured":"Bui, T. T., C. H. Piao, C. H. Song, H. S. Shin, and O. H. Chai. 2017. Bupleurum chinense extract ameliorates an OVA-induced murine allergic asthma through the reduction of the Th2 and Th17 cytokines production by inactivation of NFkappaB pathway. Biomedicine & Pharmacotherapy 91:1085\u20131095.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"2180_CR35","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s12016-018-8712-1","volume":"56","author":"ME Kuruvilla","year":"2019","unstructured":"Kuruvilla, M. E., F. E. H. Lee, and G. B. Lee. 2019. Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease. Clin Rev Allerg Immu 56:219\u2013233.","journal-title":"Clin Rev Allerg Immu"},{"key":"2180_CR36","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens, L. M., and Z. Werb. 2002. Inflammation and cancer. Nature 420:860\u2013867.","journal-title":"Nature"},{"key":"2180_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/1753465809352792","volume":"4","author":"JA Marwick","year":"2010","unstructured":"Marwick, J. A., K. F. Chung, and I. M. Adcock. 2010. Phosphatidylinositol 3-kinase isoforms as targets in respiratory disease. Therapeutic Advances in Respiratory Disease 4:19\u201334.","journal-title":"Therapeutic Advances in Respiratory Disease"},{"key":"2180_CR38","doi-asserted-by":"publisher","first-page":"4783","DOI":"10.1021\/acs.jmedchem.8b01298","volume":"62","author":"MWD Perry","year":"2019","unstructured":"Perry, M. W. D., R. Abdulai, M. Mogemark, J. Petersen, M. J. Thomas, B. Valastro, et al. 2019. Evolution of PI3Kgamma and delta Inhibitors for Inflammatory and Autoimmune Diseases. Journal of Medicinal Chemistry 62:4783\u20134814.","journal-title":"Journal of Medicinal Chemistry"},{"key":"2180_CR39","doi-asserted-by":"publisher","first-page":"8559","DOI":"10.1021\/jm300847w","volume":"55","author":"TD Cushing","year":"2012","unstructured":"Cushing, T. D., D. P. Metz, D. A. Whittington, and L. R. McGee. 2012. PI3Kdelta and PI3Kgamma as targets for autoimmune and inflammatory diseases. Journal of Medicinal Chemistry 55:8559\u20138581.","journal-title":"Journal of Medicinal Chemistry"},{"key":"2180_CR40","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1126\/science.287.5455.1049","volume":"287","author":"E Hirsch","year":"2000","unstructured":"Hirsch, E., V. L. Katanaev, C. Garlanda, O. Azzolino, L. Pirola, L. Silengo, et al. 2000. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 287:1049\u20131053.","journal-title":"Science"},{"key":"2180_CR41","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1002\/eji.200425634","volume":"35","author":"MJ Thomas","year":"2005","unstructured":"Thomas, M. J., A. Smith, D. H. Head, L. Milne, A. Nicholls, W. Pearce, et al. 2005. Airway inflammation: Chemokine-induced neutrophilia and the class I phosphoinositide 3-kinases. European Journal of Immunology 35:1283\u20131291.","journal-title":"European Journal of Immunology"},{"key":"2180_CR42","first-page":"707","volume":"63","author":"C Costa","year":"2011","unstructured":"Costa, C., E. L. Martin-Conte, and E. Hirsch. 2011. Phosphoinositide 3-kinase p110gamma in immunity. IUBMB Life 63:707\u2013713.","journal-title":"IUBMB Life"},{"key":"2180_CR43","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00018-014-1762-5","volume":"72","author":"A Plociennikowska","year":"2015","unstructured":"Plociennikowska, A., A. Hromada-Judycka, K. Borzecka, and K. Kwiatkowska. 2015. Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling. Cellular and Molecular Life Sciences 72:557\u2013581.","journal-title":"Cellular and Molecular Life Sciences"},{"key":"2180_CR44","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.3390\/ijms17111938","volume":"17","author":"X Li","year":"2016","unstructured":"Li, X., J. Shen, Y. Jiang, T. Shen, L. You, X. Sun, et al. 2016. Anti-Inflammatory Effects of Chloranthalactone B in LPS-Stimulated RAW264.7 Cells. International Journal of Molecular Sciences 17:1938.","journal-title":"International Journal of Molecular Sciences"},{"key":"2180_CR45","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1142\/S0192415X21500336","volume":"49","author":"J Byun","year":"2021","unstructured":"Byun, J., K. K. Su, and Y. B. Ju. 2021. Anti-Inflammatory and Anti-Oxidant Effects of Korean Ginseng Berry Extract in LPS-Activated RAW264.7 Macrophages. The American Journal of Chinese Medicine 49:719\u2013735.","journal-title":"The American Journal of Chinese Medicine"},{"key":"2180_CR46","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1189\/jlb.0711357","volume":"91","author":"M Yang","year":"2012","unstructured":"Yang, M., R. K. Kumar, P. M. Hansbro, and P. S. Foster. 2012. Emerging roles of pulmonary macrophages in driving the development of severe asthma. Journal of Leukocyte Biology 91:557\u2013569.","journal-title":"Journal of Leukocyte Biology"},{"key":"2180_CR47","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00018-020-03656-y","volume":"78","author":"A Ciesielska","year":"2021","unstructured":"Ciesielska, A., M. Matyjek, and K. Kwiatkowska. 2021. TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling. Cellular and Molecular Life Sciences 78:1233\u20131261.","journal-title":"Cellular and Molecular Life Sciences"},{"key":"2180_CR48","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.3389\/fimmu.2019.02492","volume":"10","author":"T Lajqi","year":"2019","unstructured":"Lajqi, T., G. P. Lang, F. Haas, D. L. Williams, H. Hudalla, M. Bauer, et al. 2019. Memory-Like Inflammatory Responses of Microglia to Rising Doses of LPS: Key Role of PI3Kgamma. Frontiers in Immunology 10:2492.","journal-title":"Frontiers in Immunology"},{"key":"2180_CR49","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.intimp.2019.02.014","volume":"69","author":"R Jiang","year":"2019","unstructured":"Jiang, R., P. Hao, G. S. Yu, C. N. Liu, C. D. Yu, Y. Huang, et al. 2019. Kaempferol protects chondrogenic ATDC5 cells against inflammatory injury triggered by lipopolysaccharide through down-regulating miR-146a. International Immunopharmacology 69:373\u2013381.","journal-title":"International Immunopharmacology"},{"key":"2180_CR50","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.3390\/ijms23031582","volume":"23","author":"DH Bai","year":"2022","unstructured":"Bai, D. H., T. X. Sun, F. Lu, Y. C. Shen, Y. Zhang, B. Zhang, et al. 2022. Eupatilin Suppresses OVA-Induced Asthma by Inhibiting NF-\u03baB and MAPK and Activating Nrf2 Signaling Pathways in Mice. International Journal of Molecular Sciences 23:1582.","journal-title":"International Journal of Molecular Sciences"},{"key":"2180_CR51","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s00011-022-01584-0","volume":"71","author":"BM Facchin","year":"2022","unstructured":"Facchin, B. M., G. O. dos Reis, G. N. Vieira, E. T. B. Mohr, J. S. da Rosa, I. F. Kretzer, et al. 2022. Inflammatory biomarkers on an LPS-induced RAW 264.7 cell model: a systematic review and meta-analysis. Inflammation Research 71:741\u2013758.","journal-title":"Inflammation Research"},{"key":"2180_CR52","doi-asserted-by":"publisher","first-page":"109483","DOI":"10.1016\/j.intimp.2022.109483","volume":"114","author":"DH Bai","year":"2023","unstructured":"Bai, D. H., Y. J. Sun, Q. Li, H. H. Li, Y. R. Liang, X. M. Xu, et al. 2023. Leonurine attenuates OVA-induced asthma via p38 MAPK\/NF-\u03baB signaling pathway. International Immunopharmacology 114:109483.","journal-title":"International Immunopharmacology"},{"key":"2180_CR53","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1007\/s10753-016-0423-2","volume":"39","author":"DZ Wei","year":"2016","unstructured":"Wei, D. Z., X. Y. Guo, L. N. Lin, M. X. Lin, Y. Q. Gong, B. Y. Ying, et al. 2016. Effects of Angelicin on Ovalbumin (OVA)-Induced Airway Inflammation in a Mouse Model of Asthma. Inflammation 39:1876\u20131882.","journal-title":"Inflammation"},{"key":"2180_CR54","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S0272-5231(05)70405-6","volume":"18","author":"DY Leung","year":"1997","unstructured":"Leung, D. Y., and S. J. Szefler. 1997. Diagnosis and management of steroid-resistant asthma. Clinics in Chest Medicine 18:611\u2013625.","journal-title":"Clinics in Chest Medicine"},{"key":"2180_CR55","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1172\/JCI116963","volume":"93","author":"ER Sher","year":"1994","unstructured":"Sher, E. R., D. Y. Leung, W. Surs, J. C. Kam, G. Zieg, A. K. Kamada, et al. 1994. Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. Journal of Clinical Investigation 93:33\u201339.","journal-title":"Journal of Clinical Investigation"},{"key":"2180_CR56","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1084\/jem.181.1.33","volume":"181","author":"DY Leung","year":"1995","unstructured":"Leung, D. Y., R. J. Martin, S. J. Szefler, E. R. Sher, S. Ying, A. B. Kay, et al. 1995. Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma. Journal of Experimental Medicine 181:33\u201340.","journal-title":"Journal of Experimental Medicine"},{"key":"2180_CR57","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1056\/NEJMoa0808991","volume":"360","author":"P Haldar","year":"2009","unstructured":"Haldar, P., C. E. Brightling, B. Hargadon, S. Gupta, W. Monteiro, A. Sousa, et al. 2009. Mepolizumab and exacerbations of refractory eosinophilic asthma. New England Journal of Medicine 360:973\u2013984.","journal-title":"New England Journal of Medicine"},{"key":"2180_CR58","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.3390\/ijms17111858","volume":"17","author":"P Marialuisa","year":"2016","unstructured":"Marialuisa, P., L. Giuseppe, and C. Daniela. 2016. The Multifaceted Roles of PI3K\u03b3 in Hypertension, Vascular Biology, and Inflammation. International Journal of Molecular Sciences 17:1858.","journal-title":"International Journal of Molecular Sciences"},{"key":"2180_CR59","doi-asserted-by":"publisher","first-page":"4749","DOI":"10.1016\/j.bmc.2004.06.022","volume":"12","author":"ZA Knight","year":"2004","unstructured":"Knight, Z. A., G. G. Chiang, P. J. Alaimo, D. M. Kenski, C. B. Ho, K. Coan, et al. 2004. Isoform-specific phosphoinositide 3-kinase inhibitors from an arylmorpholine scaffold. Bioorganic & Medicinal Chemistry 12:4749\u20134759.","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"2180_CR60","doi-asserted-by":"publisher","first-page":"40","DOI":"10.15698\/cst2021.04.246","volume":"5","author":"V Sala","year":"2021","unstructured":"Sala, V., A. Della Sala, A. Ghigo, and E. Hirsch. 2021. Roles of phosphatidyl inositol 3 kinase gamma (PI3Kgamma) in respiratory diseases. Cell Stress 5:40\u201351.","journal-title":"Cell Stress"},{"key":"2180_CR61","doi-asserted-by":"publisher","first-page":"637948","DOI":"10.3389\/fimmu.2021.637948","volume":"12","author":"B Leon","year":"2021","unstructured":"Leon, B., and A. Ballesteros-Tato. 2021. Modulating Th2 cell immunity for the treatment of asthma. Frontiers in Immunology 12:637948.","journal-title":"Frontiers in Immunology"},{"key":"2180_CR62","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nri3786","volume":"15","author":"JV Fahy","year":"2015","unstructured":"Fahy, J. V. 2015. Type 2 inflammation in asthma\u2013present in most, absent in many. Nature Reviews Immunology 15:57\u201365.","journal-title":"Nature Reviews Immunology"},{"key":"2180_CR63","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1164\/rccm.200810-1570OC","volume":"179","author":"JA Marwick","year":"2009","unstructured":"Marwick, J. A., G. Caramori, C. S. Stevenson, P. Casolari, E. Jazrawi, P. J. Barnes, et al. 2009. Inhibition of PI3Kdelta restores glucocorticoid function in smoking-induced airway inflammation in mice. American Journal of Respiratory and Critical Care Medicine 179:542\u2013548.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"2180_CR64","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jneuroim.2008.08.011","volume":"204","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y., Y. Zhang, J. Miao, G. Hanley, C. Stuart, X. Sun, et al. 2008. Chronic restraint stress promotes immune suppression through toll-like receptor 4-mediated phosphoinositide 3-kinase signaling. Journal of Neuroimmunology 204:13\u201319.","journal-title":"Journal of Neuroimmunology"},{"key":"2180_CR65","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fphar.2017.00082","volume":"8","author":"AD Wagh","year":"2017","unstructured":"Wagh, A. D., M. Sharma, J. Mahapatra, A. Chatterjee, M. Jain, and V. Addepalli. 2017. Investigation into the role of PI3K and JAK3 kinase inhibitors in murine models of asthma. Frontiers in Pharmacology 8:82.","journal-title":"Frontiers in Pharmacology"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-024-02180-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-024-02180-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-024-02180-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T05:36:50Z","timestamp":1757137010000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-024-02180-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":65,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["2180"],"URL":"https:\/\/doi.org\/10.1007\/s10753-024-02180-6","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"assertion":[{"value":"6 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}